PF-06747711
目录号: PL11084 纯度: ≥99%
CAS No. :1892576-58-7
商品编号 规格 价格 会员价 是否有货 数量
PL11084-5mg 5mg ¥1483.64 请登录
PL11084-10mg 10mg ¥2472.73 请登录
PL11084-50mg 50mg ¥8654.55 请登录
PL11084-100mg 100mg ¥14218.18 请登录
PL11084-200mg 200mg 询价 询价
PL11084-500mg 500mg 询价 询价
PL11084-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1632.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
PF-06747711
中文别名
化合物 T16495;3-氰基-N-(3-(1-异丁酰基哌啶-4-基)-1-甲基-4-(三氟甲基)-1H-吡咯并[2,3-B]吡啶-5-基)苯甲酰胺
英文名称
PF-06747711
英文别名
3-cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide;GTPL10078;BIHPJIJLDNUDGH-UHFFFAOYSA-N;BDBM189877;example 5 [WO2016046755A1];RORC2 inverse agonist 66 [PMID: 30130103];3-cyano-N-[1-methyl-3-[1-(2-methylpropanoyl)piperidin-4-yl]-4-(trifluoromethyl)pyrrolo[2,3-b]pyridin-5-yl]benzamide;US9670201, 5 3-cyano-N-(3-(1-isobut;CID 118977746;PF-06747711;3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide;3-Cyano-N-[1-methyl-3-[1-(2-methyl-1-oxopropyl)-4-piperidinyl]-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]benzamide;RORC2 Inverse Agonist;Benzamide, 3-cyano-N-[1-methyl-3-[1-(2-methyl-1-oxopropyl)-4-piperidinyl]-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-;PF-06747711 >=98% (HPLC);PF06747711,PF 06747711
Cas No.
1892576-58-7
分子式
C26H26F3N5O2
分子量
497.51
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
PF-06747711 是一种有效、选择性、可口服的视黄酸受体相关孤儿受体 C2 (RORC2 或 RORγt) 的反向激动剂,IC50 值为 4.1 nM。具有抗皮肤炎的功效。
生物活性
PF-06747711 is a potent, selective, and orally active retinoic acid receptor-related orphan C2 (RORC2, also known as RORγt) inverse agonist, with an IC 50 of 4.1 nM. Anti-skin inflammatory activity.
性状
Solid
IC50 & Target[1][2]
IC50: 4.1 nM (RORC2)
体外研究(In Vitro)
PF-06747711 (Compound 66) reduces IL-17 production by human Th17 cells with an IC50 of 9.5 nM. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
PF-06747711 (10, 30, and 100 mg/kg, p.o., daily over 5 days) inhibits ear swelling in a dose-dependent manner in mice. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: 8?10 week old fe
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Schnute ME, et al. Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agoni
溶解度数据
In Vitro: DMSO : 41.67 mg/mL (83.76 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2